Find intellectual property law content faster
Wolters Kluwer continues to provide authoritative, accurate, and timely analysis and resources to support your business entities law practice. Cheetah™ Intellectual Property Law gives you access to topic segments that include Copyright, Trademark and Advertising, Patent, and Technology and Internet.
Expert analysis and authoritative content
Leading authorities provide the insights you need including international coverage of patent and trademark requirements in over 230 jurisdictions around the world written by attorneys from each country.
Easy to use practice tools
Utilize Searchable Content and Smart Charts to access forms, checklists and practice tips to do fast, accurate preliminary research, comparing jurisdictions in easy-to-read charts that provide detailed summaries and links for further analysis.
IP Law Daily, news alerts, and international blog posts keep you on top of developments, ensuring you’re able to advise clients on how changes in the law might affect them.
Explore the types of articles and in-depth analysis available through the IP Law Daily.
German company’s patent suit against Sirius XM Radio reinstated
The district court erred by dismissing the infringement suit against the satellite radio company based on a license agreement.
Application’s claims for mode-switching handheld device improperly rejected
Prior art that disclosed a device able to transition from one operational mode to another did not disclose all limitations of the applied-for claims and therefore did not anticipate them.
Obviousness finding for fiberglass insulation patents not supported by substantial evidence
The PTAB’s finding of a motivation to combine based on similarity of the references was unsupported by substantial evidence.
Rival wood-pellet grill maker barred from using inventor's name and image
A wood pellet grill maker prevailed on a preliminary injunction claim against a rival grill maker which sought to use the grill's inventor in its advertising.
Nearly all asserted claims of patents for formulations of Horizon’s PENNSAID® 2% topical solution invalid as indefinite
Horizon also failed to show that competitor Actavis’s ANDA label induced infringement of asserted method claims.